Nachrichten zur Akero Therapeutics Inc. Aktie

Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares

SOUTH SAN FRANCISCO, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational…

Akero Therapeutics prices public stock offering at $29 per share By Investing.com

Akero Therapeutics prices public stock offering at $29 per share…

Akero Therapeutics announces pricing of stock offering to raise $319M

…

Akero Therapeutics Announces Pricing of Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company…

Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference

LEXINGTON, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company…

Akero Therapeutics launches $300 million stock offering By Investing.com

Akero Therapeutics launches $300 million stock offering…

Akero Therapeutics Announces Proposed Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company…

Akero Therapeutics reports positive EFX trial results By Investing.com

Akero Therapeutics reports positive EFX trial results…

Wall Street Analysts Predict a 58.87% Upside in Akero Therapeutics, Inc. (AKRO): Heres What You Should Know

The mean of analysts price targets for Akero Therapeutics, Inc. (AKRO) points to a 58.9% upside in the stock. While…

dpa-AFX ProFeed